Seroprevalence of nine human papillomavirus types included in the nonavalent vaccine in unvaccinated women living in Puerto Rico: A population-based study
The high seroprevalence of 9vHPV types found in our study underscores the potential benefits of following the recommended vaccine schedule to reduce HPV and cervical cancer burden in this population.
Authors
- Josefina Romaguera (ORCID: https://orcid.org/0000-0001-5403-9160)
- Teresita Campos Rivera
- Angeline Cruz (ORCID: https://orcid.org/0000-0003-4217-9654)
- Elizabeth R. Unger (ORCID: https://orcid.org/0000-0002-2925-5635)
- Jeslie M. Ramos‐Cartagena (ORCID: https://orcid.org/0000-0001-8024-1346)
- Ana Patricia Ortiz (ORCID: https://orcid.org/0000-0003-1017-9473)
- Erick Suárez (ORCID: https://orcid.org/0009-0007-2451-9527)
- Gitika Panicker
- Cynthia M. Pérez (ORCID: https://orcid.org/0000-0003-2529-7042)
Institutions
- Centers for Disease Control and Prevention (US)
- University of Puerto Rico, Medical Sciences Campus (PR)
- University of Puerto Rico System (PR)
- Barcelona Institute for Global Health (ES)
Publication Details
- Journal
- International Journal of Infectious Diseases
- Published
- 2025-11-11
- DOI
- https://doi.org/10.1016/j.ijid.2025.108195
- Primary Topic
- Cervical Cancer and HPV Research
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- National Institutes of Health
- Centers for Disease Control and Prevention
- National Cancer Institute
- National Institute of Allergy and Infectious Diseases
- National Center for Research Resources
- National Institute on Minority Health and Health Disparities